Cargando…
Insufficient antibody validation challenges oestrogen receptor beta research
The discovery of oestrogen receptor β (ERβ/ESR2) was a landmark discovery. Its reported expression and homology with breast cancer pharmacological target ERα (ESR1) raised hopes for improved endocrine therapies. After 20 years of intense research, this has not materialized. We here perform a rigorou...
Autores principales: | Andersson, Sandra, Sundberg, Mårten, Pristovsek, Nusa, Ibrahim, Ahmed, Jonsson, Philip, Katona, Borbala, Clausson, Carl-Magnus, Zieba, Agata, Ramström, Margareta, Söderberg, Ola, Williams, Cecilia, Asplund, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501969/ https://www.ncbi.nlm.nih.gov/pubmed/28643774 http://dx.doi.org/10.1038/ncomms15840 |
Ejemplares similares
-
Corrigendum: Insufficient antibody validation challenges oestrogen receptor beta research
por: Andersson, Sandra, et al.
Publicado: (2017) -
High-abundant protein depletion strategies applied on dog cerebrospinal fluid and evaluated by high-resolution mass spectrometry
por: Sundberg, Mårten, et al.
Publicado: (2015) -
Methods for analysis of the cancer microenvironment and their potential for disease prediction, monitoring and personalized treatments
por: Clausson, Carl-Magnus, et al.
Publicado: (2012) -
Effect of insulin treatment on circulating insulin‐like growth factor I and IGF‐binding proteins in cats with diabetes mellitus
por: Strage, Emma M., et al.
Publicado: (2018) -
Quantitative and Selective Analysis of Feline Growth Related Proteins Using Parallel Reaction Monitoring High Resolution Mass Spectrometry
por: Sundberg, Mårten, et al.
Publicado: (2016)